Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Regulatory News (ODX)

  • There is currently no data for ODX

US expansion update

6 Jan 2023 07:00

RNS Number : 8680L
Omega Diagnostics Group PLC
06 January 2023
 

OMEGA DIAGNOSTICS GROUP PLC

("Omega", the "Company" or the "Group")

 

US expansion update

 

Maiden US Laboratory FoodPrint® installation,

Appointment of US importer for FoodPrint® and

First PO from US CLIA certified Lab heralds start of US expansion

 

Omega (AIM: ODX), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces that it has now received the maiden purchase order ('PO') for its FoodPrint® system from a CLIA certified ('Clinical Laboratory Improvement Amendments') laboratory in the United States, and has appointed a new US importer for FoodPrint® kits.

 

Using a small finger prick of blood, the FoodPrint® test can quickly identify an individual's unique food sensitivity reactions, allowing the patient to adjust and plan to a new diet and address IgG-mediated food sensitivities. FoodPrint® analyses up to 222 foods for IgG antibodies and is trusted by more than 150 laboratories worldwide, to help fast track a guided elimination diet allowing a more focused and actionable result for practitioners and their patients.

 

The Board expects installation at the laboratory to commence later this month and after a period of validation and gaining necessary approvals, the processing of tests to begin later this quarter. As well as being CLIA certified, the laboratory receiving the system is also College of American Pathologists accredited and specialises in providing functional tests for both consumers and healthcare practitioners.

 

Omega has also secured an importer for FoodPrint® kits into the USA. The importer will import kits for the CLIA laboratory as well as for Omega's own direct channels in future.

 

Although the value of this initial PO is circa £50,000, the US market is a key area of focus for Omega's growth strategy and this installation will be the first in the US market in over seven years, representing the beginning of Omega's planned expansion into the USA.

 

Jag Grewal, CEO of Omega Diagnostics, said: "The US is the single largest market for food sensitivity testing globally, with an ever-increasing demand for personalised medicine, and is a focus area for our growth plans. This installation reflects a key milestone in our expansion plans, the receiving laboratory is ideally placed to commercialise FoodPrint® in the US market as they are already providing a range of other functional tests. The appointment of the US importer will act as a foundation for our expansion into the region.

 

"Once the system has been commissioned, we plan to collaborate closely with our laboratory partner to ensure FoodPrint® is promoted effectively through their existing healthcare practitioner and direct to consumer channels."

 

 

Contacts: 

Omega Diagnostics Group PLC 

www.omegadx.com

Jag Grewal, Chief Executive Officer 

via Walbrook PR

Chris Lea, Chief Financial Officer

finnCap Ltd  

Tel: 020 7220 0500

Geoff Nash/Edward Whiley/George Dollemore (Corporate Finance)

Alice Lane/Charlotte Sutcliffe (ECM)

Walbrook PR Limited

Tel: 020 7933 8780 or omega@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Applegarth

Mob: 07584 391 303

Sam Allen

Mob: 07502 558 258

 

About Omega Diagnostics Group PLC

Omega (AIM: ODX) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.

www.omegadx.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBAMLTMTTMBAJ
Date   Source Headline
16th Jul 20127:00 amRNSDirector/PDMR Shareholding
9th Jul 20124:35 pmRNSDirector/PDMR Shareholding
6th Jul 201210:37 amRNSDirector Dealing
6th Jul 20127:00 amRNSGrant of Options
2nd Jul 20127:00 amRNSFinal Results
19th Jun 20127:00 amRNSCollaboration with the Burnet Institute, Melbourne
16th Apr 20127:00 amRNSTrading Statement
2nd Apr 201210:51 amRNSDirector Shareholding
28th Mar 20123:08 pmRNSDirectorate Change
30th Jan 201211:57 amRNSDirector/PDMR Shareholding
17th Jan 20129:00 amRNSDirectorate Change
25th Nov 20117:00 amRNSInterim Results
7th Nov 20117:00 amRNSChange of Adviser
10th Oct 20117:00 amRNSTrading Update & Notice of Results
23rd Aug 201111:29 amRNSResult of AGM
15th Aug 20112:05 pmRNSDirector/PDMR Shareholding
4th Jul 20117:00 amRNSFinal Results
30th Jun 20111:18 pmRNSDirectorate Change
27th May 201111:58 amRNSHolding(s) in Company
24th May 20117:00 amRNSTen year exclusive distribution agreement
12th Apr 20117:00 amRNSTrading Update & Management Appointments
28th Mar 20117:35 amRNSExclusive Licence Agreement
23rd Feb 20119:20 amRNSHolding(s) in Company
17th Jan 20117:00 amRNSHolding(s) in Company
23rd Dec 201010:53 amRNSHolding(s) in Company
23rd Dec 201010:53 amRNSHolding(s) in Company
21st Dec 20104:40 pmRNSHolding(s) in Company
21st Dec 20104:36 pmRNSTotal Voting Rights
20th Dec 20103:29 pmRNSHolding(s) in Company
17th Dec 20109:51 amRNSResult of General Meeting
26th Nov 20107:00 amRNSDistribution Agreement: Food DetectiveT in India
26th Nov 20107:00 amRNSHalf Yearly Report
17th Nov 20107:00 amRNSPlacing and Acquisition
13th Oct 20107:00 amRNSTrading Statement
19th Aug 20102:32 pmRNSAGM Statement
23rd Jul 201010:20 amRNSHolding(s) in Company
16th Jul 20107:00 amRNSFinal Results
26th May 20107:00 amRNSCo-Tek supply agreement
30th Apr 20102:26 pmRNSHolding(s) in Company
13th Apr 20107:00 amRNSTrading Statement
22nd Dec 20098:43 amRNSDirectorate Change
11th Dec 20097:00 amRNSTrading Statement
27th Nov 20097:00 amRNSHalf Yearly Report
4th Nov 200910:19 amRNSHolding(s) in Company
21st Oct 20094:51 pmRNSEnd of offer period
21st Oct 200910:50 amRNSRule 8.3- Omega Diagnostics Group Plc
20th Oct 200911:52 amRNSRule 8.3- Omega Diagnostics Group Plc
20th Oct 200911:43 amRNSRule 8.3- Omega Diagnostics
19th Oct 20097:00 amRNSStatement re Possible Offer
14th Oct 200911:12 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.